ESMO: Merck piles on the positive Keytruda-chemo combo results in lung cancer

8th September 2017 Uncategorised 0

AstraZeneca is still licking its wounds from its July lung-cancer combo flop—and Bristol-Myers Squibb is dreading the possibility of producing a similar result with its own ongoing Opdivo-Yervoy study. But Merck keeps churning out positive data from its own chemo-oriented pairing.

More: ESMO: Merck piles on the positive Keytruda-chemo combo results in lung cancer
Source: fierce